Evaluating the Efficacy of Convalescent Plasma in Symptomatic Outpatients Infected With COVID-19

Summary

This study will provide investigational convalescent plasma for patients infected with the SARS-CoV-2 with mild to moderate symptoms who meet inclusion criteria as judged by physician evaluation.

Timeline

Start

2020-08-12

Primary completion

2020-08-12

Completion

2021-08-12

Drugs

Indications